Radiology
China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment
August 4, 2010 2:36 am | by Bio-Medicine.Org | News | CommentsSHENZHEN, China , Aug. 4 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or "the Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the State Administration of Foreign...
PerkinElmer acquires imaging tech firm VisEn Medical
August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | News | CommentsPerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.
Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
August 2, 2010 3:36 am | by Bio-Medicine.Org | News | CommentsTHE WOODLANDS, Texas , Aug. 2 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development...
Western European Market for Image-guided and Robot-assisted Surgery
August 2, 2010 1:39 am | by Bio-Medicine.Org | News | CommentsNEW YORK , Aug. 2 /- Reportlinker.com announces that a new market research report is available in its catalogue: Western European Market for Image-guided and Robot-assisted Surgery http://www.reportlinker.com/p0236384/Western-European-Market-for-Image-g......
Clear CT Scans with Less Radiation
August 1, 2010 8:36 pm | by Massachusetts Institute of Technology | News | CommentsResearchers are devising new ways to get the same results with fewer x-rays.
Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
July 30, 2010 12:40 pm | by Bio-Medicine.Org | News | CommentsALLEGAN, Mich. , July 30 /- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner...
FDA Approves Vaccines for the 2010-2011 Influenza Season
July 30, 2010 12:40 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , July 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States . (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom....
Mylan Announces Pricing of Add-On Offering of Senior Notes
July 30, 2010 12:40 pm | by Bio-Medicine.Org | News | CommentsPITTSBURGH , July 30 /- Mylan Inc. (Nasdaq: MYL ) today announced that it priced $300 million aggregate principal amount of Senior Notes due 2020 at an issue price of 105.5% with a coupon of 7.875%, or an effective yield to maturity of 7.087%. The notes are being offered as additional...
WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
July 30, 2010 12:39 pm | by Bio-Medicine.Org | News | CommentsSHANGHAI , July 30 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States , today announced that it will release financial results for the second...
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
July 30, 2010 12:39 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO , July 30 /- Conatus Pharmaceuticals Inc. announced today that Conatus acquired the Idun Pharmaceuticals subsidiary of Pfizer Inc. Financial terms were not disclosed. Conatus Pharmaceuticals is a privately-held drug development company focused on liver disease and...
CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010
July 30, 2010 12:39 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO , July 30 /- CareFusion Corporation (NYSE: CFN ) today announced plans to release fourth quarter and fiscal 2010 results on Tuesday, Aug. 10 following the close of trading on the New York Stock Exchange. The company will host a webcast and conference call on Aug. 10 at 2 p.m....
Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC
July 30, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsCHICAGO , July 30 /- Water Street Healthcare Partners , a leading private equity firm focused exclusively on health care, announced today that it has acquired Medical Specialties Distributors, LLC (MSD). Headquartered in Stoughton, Massachusetts , MSD is the nation's leading...
FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist
July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , July 29 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says children and pets should not come in contact with Evamist, a topical drug for women used in the treatment of hot flashes caused by menopause. (Logo:...
Launch of BioOptimalâ„¢ MF-SL Microfilters for Bioprocessing
July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | CommentsTOKYO , July 29 /- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™...
Giant Eagle® Expands Free Prescription Program to Include Free Diabetes Medicines in Northeast Ohio
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsCLEVELAND , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...
Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...
NCPA Statement on CVS Caremark-Aetna Agreement
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsALEXANDRIA, Va. , July 29 /PRNewswire-USNewswire/ -- In response to the agreement announced that CVS Caremark would provide pharmacy benefits to all 9.7 million lives covered by insurance giant Aetna, the National Community Pharmacists Association (NCPA) issued the following statement...
Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc.
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsSAVANNAH, Ga. , July 29 /- MIT Holding, Inc. announces that Walter H.C. Drakeford has been named co-president and co-chairman of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker will also serve as co-president and co-chairman of the board of directors. Drakeford's...
Analysis Finds U.S. Medical-Surgical Manufacturers Using GHX Market Intelligence Grew Revenue Faster Than Non-Users in 2009
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsLOUISVILLE, Colo. , July 29 /- An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution...
Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010
July 29, 2010 9:34 am | by Bio-Medicine.Org | News | CommentsAUSTIN, Texas , July 29 /- Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host a web cast and conference call to give a company update following issuance of Q2 financial results on Monday, August 16, 2010 . Conference Call Information To access the live...
Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
July 29, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 29 /- Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint...
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
July 29, 2010 4:37 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO , July 29 /- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced that six of six patients (100%) in the ANA598 200 mg twice daily (bid) arm who were randomized to stop all treatment at Week 24 in an ongoing Phase II trial maintained undetectable levels of virus 12 weeks...
Free For All® Inc., MMM and PMC Assist Members with Pharmacy Discount
July 29, 2010 4:37 am | by Bio-Medicine.Org | News | CommentsMARLTON, N.J. , July 29 /- Free For All® Inc., MMM Healthcare, Inc. (MMM) and PMC Medicare Choice, Inc. today announced a plan to offer MMM/PMC members access to medications, lab testing and medical imaging at substantial rate reductions with the use of RxCut®Plus cards. The...
FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q & A with Michael Klein, Ph.D.
July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , July 28 /PRNewswire-USNewswire/ -- Dr. Michael Klein , director of the Food and Drug Administration (FDA) Controlled Substance Staff, discusses how FDA works with other entities to confront and to prevent misuse and abuse of prescription drugs. (Logo:...
New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | CommentsWASHINGTON , July 28 /PRNewswire-USNewswire/ -- In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements , Joy Sturm , Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how...
